Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: District of Columbia 25 trials found
New Search
Filter
Trial Phase
Study Type
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
NAINTERVENTIONAL La Jolla, California +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
PHASE2INTERVENTIONAL West Los Angeles, California +4 more
RECRUITING
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
NAINTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
PHASE2, PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
PHASE1, PHASE2INTERVENTIONAL Costa Mesa, California +4 more
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
PHASE2, PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Older Breast Cancer Patients: Risk for Cognitive Decline
N/AOBSERVATIONAL Washington D.C., District of Columbia
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
PHASE1, PHASE2INTERVENTIONAL Santa Rosa, California +4 more
RECRUITING
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
PHASE1INTERVENTIONAL Washington D.C., District of Columbia +3 more
RECRUITING
Filter Trials
Trial Phase
Study Type